The generation of synthetic ligands of LXR should be pursued [41], given its central role in dimerization with RXRA. The possible PI3P-dependent activation of OSBPL10 could be tested through the various PI3K inhibitors being developed in cancer treatment [42]. This evidence concerns the gene OSBPL10 and cancer.